+ PhaseI-Support-non-clinical-strategy-advice

Non-Clinical Strategy

Our senior scientists and programme managers readily contribute their vast experience to strategic discussions with customers. Our experience ranges across a broad spectrum of therapeutic areas and drug types: ranging from novel small molecules and retargeted existing drugs to innovative biologicals.


Our regulatory and study design experience enables us to propose testing strategies that are firmly science based yet focussed on practical implementation.  We have an outstanding record in achieving regulatory approval for our proposed strategies.


  • Initial feasibility advice
  • Design of first-in-man testing programmes
  • Assistance with obtaining regulatory approval of non-clinical strategy
  • Specialist advice on species selection
  • Honest capability assessment with outsourcing of technical expertise where necessary
  • Creative study design
  • Focus on animal reduction, replacement and refinement initiatives

Our News & Events
MDC Connects Webinar 8: Is my Compound Safe?
1 June 2020
Join Sequani for the how to get your molecule in to humans webinar
Read More
Mice in Juvenile Toxicity Testing
26 November 2018
Mice in Juvenile Toxicity Testing
Read More
Biomarker Validation – Mountain, Molehill or Something in Between?
13 June 2018
Biomarker Validation – Mountain, Molehill or Something in Between?
Read More